Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,513.00 JPY | -3.59% |
|
-2.39% | +14.02% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 9,130B 57.26B 49.74B 46.19B 42.59B 80.23B 5,467B 81.69B 547B 214B 2,715B 215B 210B | P/E 2027 * |
45.9x | P/E 2028 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise Value | 13,064B 81.93B 71.16B 66.08B 60.95B 115B 7,822B 117B 782B 306B 3,885B 308B 301B | EV / Sales 2027 * |
2.8x | EV / Sales 2028 * | 2.72x |
| Free-Float |
99.28% | Yield 2027 * |
3.57% | Yield 2028 * | 3.66% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -3.59% | ||
| 1 week | -2.39% | ||
| Current month | +6.94% | ||
| 1 month | +7.05% | ||
| 3 months | +5.23% | ||
| 6 months | +3.20% | ||
| Current year | +14.02% |
| 1 week | 5,438 |  | 5,903 |
| 1 month | 5,190 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% | ||
| 10/07/26 | Issuer sale | President, Japan Pharma B.U. | -1,022 | 0.0001% | ||
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.59% | -2.39% | +31.26% | +27.00% | 57.26B | |
| -4.55% | -2.61% | +51.95% | +151.91% | 1,030B | |
| -3.66% | -1.33% | +52.95% | +46.62% | 617B | |
| -2.24% | +0.19% | +35.97% | +70.64% | 455B | |
| +0.78% | +0.34% | +38.58% | +31.67% | 350B | |
| +0.43% | +0.22% | +35.02% | +39.65% | 299B | |
| +0.01% | +0.38% | +12.31% | +13.70% | 265B | |
| -9.50% | -6.71% | -4.90% | -45.23% | 225B | |
| 0.00% | +4.34% | +28.63% | +64.00% | 209B | |
| -1.09% | +0.32% | +14.40% | +70.80% | 163B | |
| Average | -1.66% | +4.88% | +29.62% | +47.08% | 366.99B | |
| Weighted average by Cap. | -0.90% | +4.88% | +37.81% | +70.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,662B 29.24B 25.4B 23.58B 21.75B 40.97B 2,791B 41.71B 279B 109B 1,386B 110B 107B | 4,740B 29.72B 25.82B 23.98B 22.11B 41.65B 2,838B 42.4B 284B 111B 1,409B 112B 109B |
| Net income | 186B 1.17B 1.01B 940M 867M 1.63B 111B 1.66B 11.13B 4.36B 55.25B 4.38B 4.28B | 313B 1.97B 1.71B 1.59B 1.46B 2.75B 188B 2.8B 18.76B 7.35B 93.17B 7.38B 7.22B |
| Net Debt | 3,934B 24.67B 21.43B 19.9B 18.35B 34.57B 2,355B 35.19B 236B 92.24B 1,170B 92.64B 90.61B | 3,784B 23.73B 20.61B 19.14B 17.65B 33.25B 2,266B 33.86B 227B 88.73B 1,125B 89.12B 87.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | JP¥5,513.00 | -3.59% | 7,218,600 |
| 30/07/26 | JP¥5,718.00 | -2.21% | 4,859,800 |
| 29/07/26 | JP¥5,847.00 | +1.79% | 5,289,600 |
| 28/07/26 | JP¥5,744.00 | -0.43% | 3,918,100 |
| 27/07/26 | JP¥5,769.00 | +2.14% | 4,647,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
